Showing results (111-120 of 187) with videos related to

Sort By:
Pageof 19
Rheumatology (Oxford, England)|July 8, 2023
Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue diseaseYasuyuki Todoroki, Minoru Satoh, Satoshi Kubo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 13, 2015
Endothelial dysfunction is associated with the severity of cerebral small vessel diseaseTomohisa Nezu, Naohisa Hosomi, Shiro Aoki, et al.
Modern Rheumatology|November 23, 2013
Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR studySatoshi Kubo, Kazuyoshi Saito, Shintaro Hirata, et al.
Rheumatology (Oxford, England)|December 19, 2017
Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related diseaseSatoshi Kubo, Shingo Nakayamada, Jidong Zhao, et al.
Annals of the Rheumatic Diseases|June 2, 2018
Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factorsXiaoxue Ma, Shingo Nakayamada, Satoshi Kubo, et al.
RMD Open|March 9, 2022
Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related diseaseSatoshi Kubo, Ryuichiro Kanda, Aya Nawata, et al.
Arthritis Research & Therapy|June 17, 2020
Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiationYusuke Miyazaki, Shingo Nakayamada, Satoshi Kubo, et al.
Arthritis Research & Therapy|November 30, 2013
Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational studyShintaro Hirata, Kazuyoshi Saito, Satoshi Kubo, et al.
RMD Open|May 18, 2026
Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST RegistrySatoshi Kubo, Yoshiya Tanaka, Yusuke Miyazaki, et al.
Arthritis Research & Therapy|June 24, 2019
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's diseaseIppei Miyagawa, Kazuhisa Nakano, Shigeru Iwata, et al.
Pageof 19